Markt geöffnet· · USD · Daten können verzögert sein
Kurse können verzögert sein und dienen nur zu Informationszwecken - keine Anlageberatung.
The past six months have been a windfall for GEO Group’s shareholders. The company’s stock price has jumped 87.3%, hitting $30.57 per share. This was partly thanks to its solid quarterly results, and the run-up might have investors contemplating their next move.
Check out the companies making headlines yesterday:
Shares of private corrections company GEO Group (NYSE:GEO) jumped 3.7% in the afternoon session after Georgia Public Broadcasting reported that the Department of Homeland Security signed construction contracts worth over $7 billion to expand immigration detention in New York, Texas, Arizona, Florida, and California, with further expansion planned in Colorado, Washington, and Pennsylvania. A planning document says ICE is looking for “mobile detention facilities” run by GEO’s transportation subsid
GEO Group has delivered a very strong run in recent years, and traders now have to ask whether the current share price lines up with what its earnings can reasonably support. With the stock nearer the top of its recent range, the key issue is how much of the company’s profit story is already embedded in that US$31.76 quote. The share price return over the past 5 years is 349.2%, which puts real weight on the question of how closely the valuation tracks GEO Group's underlying profit...
While profitability is essential, it doesn’t guarantee long-term success. Some companies that rest on their margins will lose ground as competition intensifies — as Jeff Bezos said, “Your margin is my opportunity”.
DALLAS & LYON, France, September 03, 2026--Regulatory news: SMAIO (Software, Machines and Adaptative Implants in Orthopaedics – Euronext Growth Paris, ISIN code: FR0014005I80 / Ticker: ALSMA, PEA-PME eligible), a French-American company specialized in complex spine surgery and offering an integrated pre-, intra- and postoperative solution based on 3D planning software, adaptive implants and related services, today announces the renewal of the term of office of Dr Donald J. Blaskiewicz, a neurosu
Aktuelle Schlagzeilen Dritter zu diesem Unternehmen, getrennt von Makklers eigener Redaktion und mit Verlinkung zum Herausgeber. Für die Richtigkeit ist der jeweilige Herausgeber verantwortlich.